← Back to patent-cliff list
Camphor/Menthol/Methyl Salicylate
Tier C — Watch / tradeCamphor/Menthol/Methyl Salicylate
-
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：TRPM8
Indications (approved)：昆虫咬伤和螫伤, Pain, Headache, 头晕
Regional status
US
-
EU
-
China
Approved
1996-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Camphor/Menthol/Methyl Salicylate?
Approved indications include: 昆虫咬伤和螫伤, Pain, Headache, 头晕.
When does the Camphor/Menthol/Methyl Salicylate patent expire?
No public expiry year is available for Camphor/Menthol/Methyl Salicylate yet; this page updates once verified.
How do I get a quote for Camphor/Menthol/Methyl Salicylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04